Beneficial effects of the Ca2+ sensitizer EMD 57033 in exercising pigs with infarction‐induced chronic left ventricular dysfunction
- 1 October 2001
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 134 (3) , 553-562
- https://doi.org/10.1038/sj.bjp.0704292
Abstract
1. It is unknown how cardiac stimulation by Ca(2+) sensitization modulates the cardiovascular response to exercise when left ventricular (LV) function is chronically depressed following a myocardial infarction. We therefore investigated the effects of EMD 57033 at rest and during exercise and compared these to those of the mixed Ca(2+)-sensitizer/phosphodiesterase-III inhibitor pimobendan. 2. Pigs were chronically instrumented for measurement of cardiovascular performance. At the time of instrumentation, infarction was produced by coronary artery ligation (MI, n=12). Studies in MI were performed in the awake state, 2 - 3 weeks after infarction. 3. MI were characterized by a lower resting cardiac output (18%), stroke volume (30%) and LVdP/dt(max) (18%), and a doubling of LV end-diastolic pressure, compared to normal pigs (N, n=13). 4. In 11 resting MI, intravenous EMD 57033 (0.2 - 0.8 mg kg(-1) min(-1)) increased LVdP/dt(max) (57+/-5%) and stroke volume (26+/-6%) with no effect on heart rate, LV filling pressure, and myocardial O(2)-consumption, similar to N. 5. In MI, the effects of EMD 57033 (0.4 mg kg(-1) min(-1), IV) on stroke volume and LVdP/dt(max) were maintained during treadmill exercise up to 85% of maximal heart rate, while heart rate was lower compared to control exercise (all P<0.05). In contrast, the effects of EMD57033 gradually waned in N at increasing intensity of exercise. 6. Compared to N, the cardiostimulatory effects of pimobendan (20 microg kg(-1) min(-1), IV) were blunted in MI both at rest and during exercise compared to N. 7. In conclusion, the positive inotropic actions of the Ca(2+) sensitizer EMD 57033 are unmitigated in resting and exercising MI compared to N, while those of the mixed Ca(2+)-sensitizer/phosphodiesterase-III inhibitor pimobendan are blunted.Keywords
This publication has 48 references indexed in Scilit:
- Beneficial effects of a Ca 2+ sensitizer, MCI-154, on the myocardial oxygen consumption–cardiac output relation in patients with left ventricular dysfunction after myocardial infarction: Comparison with dobutamine and phosphodiesterase inhibitorAmerican Heart Journal, 1997
- Oxygen-Saving Effect of a New Cardiotonic Agent, MCI-154, in Diseased Human HeartsJournal of the American College of Cardiology, 1997
- Effects of Pimobendan on Exercise Tolerance and Quality of Life in Patients with Heart FailureCardiology, 1997
- Systemic and Coronary Hemodynamic Actions and Left Ventricular Functional Effects of Levosimendan in Conscious DogsJournal of Cardiovascular Pharmacology, 1995
- Inotropic agents with calcium-sensitizing propertiesCoronary Artery Disease, 1994
- The Two Mechanisms of Action of Racemic Cardiotonic EMD 53998, Calcium Sensitization and Phosphodiesterase Inhibition, Reside in Different EnantiomersJournal of Cardiovascular Pharmacology, 1993
- Cardiovascular effects of dopamine and dobutamine in conscious pigs with chronic heart failureCritical Care Medicine, 1993
- Acute Hemodynamic Effects of Nisoldipine and Pimobendan in Conscious Pigs with Chronic Heart FailureJournal of Cardiovascular Pharmacology, 1989
- Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1989
- Decreased incidence of ventricular fibrillation after an acute coronary artery ligation in exercised pigsBasic Research in Cardiology, 1983